NCT01890200: The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III) |
|
|
| Withdrawn | 3 | 0 | RoW | Peginterferon alfa-2a, Pegasys, Ribavirin, Rebetol, TCM-700C, Placebo, Placebo, without acting ingredient. | TCM Biotech International Corp. | Chronic Hepatitis C | 03/18 | 06/18 | | |
